News Novartis' Arzerra gains CLL approval Development partner Genmab says drug approved in relapsed disease.
News Sandoz's Enbrel biosimilar approved in US FDA approves first near-copy of inflammatory diseases drug.
Views & Analysis The biggest pharma stories of 2016 so far The top 10 pharma milestones of the year to date.
News Novartis drug effective in advanced MS Siponimod slowed disability progression in secondary progressive multiple sclerosis
News Decision to axe Afinitor 'confirms worst fears’ for Cancer D... NICE reviewing 'legacy drugs' to free up CDF funds
Cancer Novartis’ breast cancer drug LEEO11 gains breakthrough statu... Drug will challenge Pfizer's Ibrance
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
